Turner Investments’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-16,428
Closed -$726K 228
2016
Q4
$726K Hold
16,428
0.29% 123
2016
Q3
$658K Sell
16,428
-98,930
-86% -$4.2M 0.22% 132
2016
Q2
$5.51M Sell
115,358
-18,882
-14% -$799K 1.73% 8
2016
Q1
$5.63M Buy
134,240
+69,608
+108% +$2.73M 1.53% 11
2015
Q4
$2.85M Buy
+64,632
New +$2.8M 0.59% 61
2015
Q3
Sell
-23,390
Closed -$1.36M 255
2015
Q2
$1.36M Buy
+23,390
New +$1.26M 0.25% 134
2014
Q2
Sell
-18,990
Closed -$825K 568
2014
Q1
$825K Buy
+18,990
New +$846K 0.02% 469

Other funds holding CNMD

Turner Investments's CNMD Position: Q1 2017 in Review

Turner Investments sold out of CONMED (CNMD) in Q1 2017, closing a stake of 16,428 shares — an estimated $726K sold.

Turner Investments first reported a position in CNMD in Q1 2014 and held it in 7 quarters. The position peaked at $5.63M in Q1 2016. 142 funds tracked by Wall St. Rank hold CNMD as of Q1 2017.

  • Turner Investments reported no remaining CONMED position as of Q1 2017 after selling out during the quarter.
  • Turner Investments sold 16,428 CONMED shares in Q1 2017, an estimated $726K.
  • Turner Investments first reported a position in CONMED in Q1 2014 and held it in 7 quarters.
  • Turner Investments's CONMED position peaked at $5.63M in Q1 2016.
  • 142 funds tracked by Wall St. Rank held CONMED as of Q1 2017.

Based on Turner Investments's 13F filing for Q1 2017, filed 11 May 2017.